A new digital platform for home purchases and mortgages has expanded in the Lone Star Stat. Photo via Getty Images

Tomo Networks, a fintech startup that operates a digital platform for home purchases and mortgages, has expanded its offerings statewide after launching in the summer of 2021 in Houston and Dallas.

Founded in October 2020 by former Zillow Group executives Greg Schwartz and Carey Armstrong, Tomo launched over the summer with a $70 million seed funding round led by Ribbit Capital. DST Global, NFX, SVB Capital, and Zigg Capital participated in the seed round.

“Tomo’s cutting-edge platform is unlike anything else available to homebuyers,” Nick Huber, a partner at Ribbit Capital, says in a news release. “The real estate market has not been skewed toward the buyer in quite some time, and we saw a huge opportunity to get behind a company that will do just that.”

A recent analysis of the Houston home market by Skylar Olsen, principal economist at Tomo, shows Bayou City remains among the most affordable U.S. markets and continues to provide homeownership opportunities.

According to the Tomo analysis, the gap in Houston between millennials’ share of the population and their share of total housing value has improved, shrinking from 9.7 percentage points to 9 percentage points in 20 years. “Millennials make up the largest generation of Houston’s total population,” the analysis says.

In November, the median price of a home in the Houston area rose 16.3 percent to tie the record high of $314,000 set in June, the Houston Association of Realtors says.

Tomo, based in Stamford, Connecticut, bills itself as “the first platform in the real estate space that is specifically focused on the buyer experience.” The company believes its digitally oriented approach holds strong appeal for millennials and other young homebuyers.

Tomo guarantees an on-time closing and a price match, meaning that if you find a better deal, the company will match it. Tomo says it cuts the time for mortgage preapproval by as much as 55 percent.

The company initially launched in Houston and Dallas as well as Seattle. Aside from its headquarters in Connecticut, Tomo maintains offices in Austin and Seattle. In Dallas, the startup recently rolled its first-ever ad campaign.

“In today’s housing market, buying is not an enjoyable experience; it has become competitive, stressful, and confusing, and too many people are coming away from it empty-handed. As single-family homes become commoditized by investors, the American dream is moving further and further out of reach. We are going to change that,” says Schwartz, CEO of Tomo.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.